chrisvoncsefalvay/vaers-outcomes huggingface dataset:
low fever; Fatigue/tired; Weakness; Numbness; This is a spontaneous report from a contactable consumer. This is a second case out of 2 cases. (patient reported for self). A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0180; Expiration date: UNKNOWN) via an unspecified route of administration, administrated at Arm Left on 10Jun2021 as dose 2, single for COVID-19 immunisation. The medical history type 2 diabetes mellitus from an unknown date and unknown if ongoing. The concomitant medications were not reported. The patient had earlier received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE /Lot number: EW0187) via an unspecified route of administration, administrated at left arm on 20May2021 for COVID-19 immunization. On an unspecified date, after the second dose the patient has been going through a lot of fatigue/tired, weakness, numbness. The patient stated after dose 2 he did not feel any change. He meant he was okay. The patient stated as far as he remembers almost every day, has been getting temperatures. Low fevers. The patient stated he did not feel anything, any serious kind of a thing that was just temperature was up and down that he could feel, and he was taking Ibuprofen. The patient stated now they were concerned that was has been a little longer than that and almost 20 days especially for his wife, she is experiencing the same kind of symptoms every day. The patient clarified that he was treated with Ibuprofen for pain or for the fever. Outcome of the events was unknown. Further probing could not be done. Limited information available over the call.  Follow-up attempts are completed.  No further information is expected.
Patient received undiluted Pfizer dose, 150mcg. This was dose 2 in series. On 10/29, patient reported fever (Tmax 100.1), aches, fatigue. Took acetaminophen 1000mg and Ibuprofen 800mg with relief of symptoms and fever. On 10/30, patient reported feeling better, arm still sore.
This case was reported by a vaccine regional medical scientist by a sales representative and described the occurrence of rotavirus infection in a subject of unspecified age and gender who was vaccinated with ROTARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of ROTARIX (unknown). At an unspecified time after vaccination with ROTARIX, the subject experienced severe rotavirus infection and was hospitalized. No additional information was provided.
blotchy skin rash on her torso, face and arms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Nov2021 as dose 3 (booster), single (Lot number: FJ1620) at the age of 67 years for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 2, SINGLE Lot No: EN6200), administration date: 23Feb2021, when the patient was 67-year-old, for Covid-19 Immunization; BNT162b2 (DOSE 1, SINGLE Lot No: EL9265), administration date: 02Feb2021, when the patient was 67-year-old, for Covid-19 Immunization. The following information was reported: RASH MACULAR (non-serious) with onset Dec2021, outcome "recovered with sequelae", described as "blotchy skin rash on her torso, face and arms". Therapeutic measures were not taken as a result of rash macular.
had like sort of a hard time breathing; got really weird smell; lips and her tongue were all this kind of swelled and then like it was steamed; lips and her tongue were all this kind of swelled and then like it was steamed; her arm, both of her arms went numb; could not go to sleep; This is a spontaneous report from a contactable consume r(patient). This 71-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Jan2021 at single dose (Lot # EL8982) for covid-19 immunisation. Medical history included stated, the only thing was got the susceptible to blood clots, had that gene so that is one of the reasons took the vaccine other than that did not take any meds. The patient didn't even take any blood thinners because did not need them." (not clarified further). No concomitant therapy included. The patient did not know if it is the vaccine but she got really weird smell and then her lips and her tongue were all this kind of swelled and then like it was steamed. The patient stated, "In the tongue and my lips, it was like when you get chilli on them and a distinct type of smell. " And then her arm, both of her arms went numb and she had like sort of a hard time breathing. Now, that it went away but she just waited and waited and it lasted almost in the most of the night and then she could not go to sleep but it was something she had never had before and it was very strange. She did not know if you have that kind of reaction from people or you know if it has come up but she thought she better report it because she had not had my second dose yet. She had to get the second dose on 09Feb. No treatments were received. Outcome of the events was recovering.
After about 6 days, the arm started to swell and turn bright red.  It was itchy and hot.  Started diphenhydramine on Wednesday.  At day 9 she added zyrtec and has been icing the arm.  At day 10 the swelling has gone down some and it does not itch as much.
Pfizer covid vaccine was stored outside of manufacturer's recommendation. Specifically, the vaccine was frozen longer than recommended. Patient was re-vaccinated on 12/02/21 as recommended by Pfizer.
Pain when using my left hip which was replaced more than five years ago and has not given me any problems until now.
Report received from a MD on 23-Nov-2009 on behalf of his wife who is the patient.  A 40 year-old female patient received H1N1 (Pre-filled syringe lot 00949611A) which was administered IM deltoid.  The vaccine was administered to the patient by her husband, who is also a physician, in their home at 9:00 PM on 20-Nov-2009.  The patient has a medical history of allergy to Thimerasol, and had a prior allergic reaction to a prior flu vaccination (product contained Thimerasol) when the patient was 33 years of age (??-???-1999).  On 21-Nov-2009, 15 hours 30 minutes after the H1N1 vaccine was administered (12:30 PM), the patient developed the following adverse reactions: severe nausea, dysphagia, conjunctival infection followed by eye discharge, and swollen joints.  She also experienced myalgia and arthralgia for 24 hours.  The company assessed the event causality as possible in relation to the suspect drug.  Information derived from this AE report does not change the safety profile of the product.
This case was reported by a consumer and described the occurrence of tingling extremities in an adult female pt who received Lyme disease vaccine recombinant (Lymerix). A physician or other health care professional has not verified this report. On an unspecified date in 2002, the pt received a dose of Lymerix (dose number not specified). At an unspecified number of months following the admin of Lymerix in Apr2004, the pt experienced tingling and numbness of her hands, feet, arms, and legs. The pt was see at a physician's office. The events were unresolved. The pt declined to grant authorization for man to contact her physician.
VAERS reporting as required by law, death occurred on 11/02/2021. Moderna COVID 19 vaccine completed on 01/19/2021 and 2/17/2021.
This spontaneous report as received from a licensed practical nurse refers to a male patient of unknown age. No information on the patient's concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On 10-OCT-2016, the patient was vaccinated intramuscularly with an improperly stored dose of PNEUMOVAX 23 injection (lot # L017265 with expiry date on 10-FEB-2017 or lot # L040456 with expiry date on 10-MAY-2017 (it was unspecified which lot # was administered) (dose and anatomical location were not reported). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Narrative:  psychiatric history of Schizoaffective disorder, h/o catatonic episodes, selective mutism, complex PTSD, and multiple psychiatric admissions. Unexpected Death. She was admitted for schizophrenia and bipolar disorder. Coded 5 days after 2nd Pfizer COVID dose. Unknown cause of apnea/cardiac arrest. Pt also received clozapine and ziprasidone night before event. Pt had been compliant with psych meds as outpt. RCA occurred. Autopsy revealed no abnormalities with brain, heart or lungs, no embolic events seen.
Knot at site of injection. Pain in pinky and ring finger on hand of the same arm the vaccinations were given.
2 full-term pregnancies, 1 current pregnancy 30 weeks and 3 days, and 1 SAB EDD: 12/22/2023  No adverse reactions to event that occurred.
Itching at the vaccine site started about an hour or so after injection. Soreness in the muscle started about 6 hours after injection. Itching continued. Upon waking up the following morning, no more itching, but a raised hard lump at the injection site present. It?s about the size of a quarter, hot to the touch, and extremely sore. As the morning progressed, I felt tightness and burning in my chest upon inspiration that has progressively gotten worse throughout the day. Around 12:30 I have developed a headache and I feel very fatigued.
This spontaneous report has been received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates (reported as on unspecified dates or after 05-JUN-2017), the patients were vaccinated with improperly stored doses of ROTATEQ lot # M040267, expiration date 14-MAY-2018 and lot # M041184, expiration date 31-MAY-2018, orally (dose was not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion between 32 to 35 degrees Fahrenheit for 8 hours. Digital data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1709USA011077.
1st dose- numbness/tingling in bilateral hands and feet; severe cough, congestion, boggy headache, fatigue 2nd dose- paresthesia on bilat arms, hands, legs, and feet; extreme pain, rash on left lower extremity.
around 3:35pm - pt complained of tickling and dizziness.  There was no benedryl in the emergency bag, so we sent a staff member to get benedryl.  at 3:45pm administered 50mg of benedryl orally.  no improvement, rash continued on throat.  called 911 at 3:58pm,  Pt observed by EMS, then refused EMS services.  Continued monitoring pt until 5:15pm when family picked them up.
Sore arm on day 1. Day 2: numbness and tingling in left arm and left leg. Migraine son left side of head and left ear pain. Fever, body aches, and sweats. A week later, Vertigo, and numbness/tingling reoccurred.
The patient was diagnosed with Hepatitis A within the last year after traveling overseas; This spontaneous report was received from a company representative regarding a female patient of unknown age. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies and concomitant therapies were unknown by the reported.   On unspecified date in 2012 (reported as 7 years ago), the patient was vaccinated with the first dose of Hepatitis A Vaccine, Inactivated (VAQTA) and in 2013 (reported as 6 years ago) the second dose for prevent hepatitis A (strength, dose, frequency, lot number and expiration date were not reported).   On unspecified date in 2018 (reported as within last year), the patient was diagnosed with hepatitis A after traveling overseas. The patient did not received any treatment, and the patient went to the doctors office for sought medical attention.  At the reporting time, the outcome of the event was reported as recovering (doing well).   The causal relationship between the event and therapy with Hepatitis A Vaccine, Inactivated (VAQTA) was not reported.
This case was reported by a physician via sales rep and described the occurrence of fever in a male patient who received Rabies Vaccine for prophylaxis. On an unknown date, the patient received the 3rd dose of Rabies Vaccine. On an unknown date, unknown after receiving Rabies Vaccine, the patient experienced fever and myalgia. The patient was treated with ALEVE. On an unknown date, the outcome of the fever and myalgia were unknown. The reporter considered the fever and myalgia to be possibly related to Rabies Vaccine. Additional details were provided as follows: It was unknown if the patient started Rabies vaccine prior or post exposure to the infection. The age at vaccination was not reported. The physician reported that, his son experienced a fever (body temperature: 103 degree F) and myalgia. After consulting with one of the Advisory Committee on Immunization Practices (ACIP) voting member, the physician discovered that this could occur with the rabies vaccine. The patient was advised to take some ALEVE after the 4th dose. The patient was able to complete the 4 dose series. The reporter did not agree to follow up. Lab Comments: On unknown date, the patient's body temperature was recorded as 103 degree F.
I have been having bouts of hot flashes/excessive sweating, accompanied by shortness of breath, since the day after the first vaccine shot.
Information has been received from a physician and a Registered Nurse for GARDASIL, a Pregnancy Registry Product, concerning a female infant. The infant's mother (captured in case # 1101USA03064) was vaccinated IM inadvertently with a 0.5ml dose of GARDASIL (lot#666162/0565Z) instead of an unnamed influenza vaccine on 25-JAN-2011. Concomitant therapy included prenatal vitamins (unspecified). On an unspecified date, a pregnancy test ultrasound was performed and found pregnancy. Patient's last menstrual period was 15-NOV-2010. Expected date of delivery was 22-AUG-2011. On 24-JUL-2011 at 35 weeks and 6 days of gestation, the mother delivered a female baby (premature baby), with apgar score were 8 and 9, birth weight 4 lbs 15.8 Oz. Pediatric medical records were received and reviewed; no adverse experiences related to the prenatal exposure or to other Merck Products were identified. Additional information is not expected.
Doses were administered after 24 hs of the first puncture of the vial; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses were administered after 24 hs of the first puncture of the vial) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 050C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses were administered after 24 hs of the first puncture of the vial). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses were administered after 24 hs of the first puncture of the vial) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported. Doses were administered after 24 hs of the first puncture of the vial. Doses were administered between 24 and 30 hs total after first puncture of the vial.
Per the caregiver, the patient developed dizziness after the 15 minute post COVID vaccine  observation. Caregiver advised the patient to tell the nurse about it but patient stated that she wants to just leave. While walking to the car, the patient was still conversant and still dizzy. In the car, the patient was noted to be none conversant. Caregivers asked for assistance. Code Assist was called at 3:50 PM. MD and nurses arrived, VS were within normal, patient was just having blank stares and not responsive to verbal commands. 911 was called. EMS arrived and took over. At 4:08 PM, the patient got out of the car and transferred to the gurney. Patient was awake and still not responding to questions.
This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE PAIN (arm was sore after receiving the vaccine (where she received the shot)) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J020A) for COVID-19 vaccination.  No Medical History information was reported.  On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (arm was sore after receiving the vaccine (where she received the shot)). At the time of the report, VACCINATION SITE PAIN (arm was sore after receiving the vaccine (where she received the shot)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.
I went to primary doctor for an unrelated issue, he listens to my heart, he said that my heart was elevated and that I needed to go to the hospital; I went to the ER unit, and I was there for 5 days; now I am in a care of a Cardiologist and Pulmonary. My only symptom was a short of breath but since I have asthma, I thought that it was due to the asthma condition. My heart is now working at 30% of its capacity.
Patient came to pharmacy to get the flu shot. In the room, she asked me about the other vaccine if she can get it with the flu shot. I thought she was taking about the covid booster. I gave her the covid booster and I told i will go get your paperwork for the covid shot. but it turned out she wanted the pneumonia vaccine.
8 days from getting vaccine, woke up with arm swollen/painful along with a rash just below the injection site.
TDAP 12/29/2010 2 days later developed a rash, redness, swelling itching over sight. Prescribed - KEFLEX 1/3/11. No problem with TD in past. Is this a pertussis reaction can she get TD in the future?
Parents called at 4:58 PM, pt. presented with dizziness, nausea and vomiting 30 min. after vaccine was administered. Per Dr., parent to give Benadryl to pt., increase fluids and call him in 30 min if not better.
I received my second booster which was a Pfizer vaccine. I had the typical sore arm like I did with the J&J and moderna shots previously, it was normal. A few days later I developed a scab on the back of my scalp. It wouldn?t heal and began spreading.  My scalp is burning and oozing now. Today I was diagnosed with psoriasis. I believe I have psoriasis from the last vaccine I received. I?ve also been having an unusual amount of headaches.
Client came in to the vaccination clinic requesting a second dose of Moderna vaccine.  Due to her age, we researched the first vaccine and found that Moderna was documented on her  vaccination card, but Pfizer was documented .  The client's father initially stated that he thought she received Moderna because there were four family members being vaccinated together and he thought they all received Moderna, but states he is not sure.  Unable to determine which vaccine was actually administered.N/A
This spontaneous report as received from a registered pharmacist refers to 4 patients of unknown age and gender. On an unknown date in 2014, the patients were inadvertently vaccinated with expired doses of PNEUMOVAX 23 (lot # J011651 exp 22-AUG-2014) intramuscularly. No adverse effects were reported. Additional information has been requested.
3-4 days after vaccination my heart beat started to be irregular and I breathed harder while active, this escalated until I went to urgent care 11 days after vaccination. I have been diagnosed with pericarditis, pleuritis, and overactive neutrophils. In addition to heart inflammation which causes chest pain, especially after any activity, I have had post-covid syndrome.  This includes: headaches, brain fog, extreme fatigue. I also have had some nerve numbness in my arms and leg. These symptoms will occasionally lessen with high doses of ibuprofen, but have come back after stopping ibuprofen.
Pt was supposed to receive her influenza vaccine but received a Pfizer vaccine.  Pharmacist pre drew a Pfizer vaccine.  technician giving vaccines administered the pre-drew Pfizer instead of the influenza.
exposed at room temperature for 906  hours; This case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 73-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 2372H, expiry date unknown) for prophylaxis.   On 9th July 2021, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional details were provided as follows: Pharmacist reported that the patient was administered Boostrix which was exposed at room temperature for 906 hours, which led to incorrect storage of drug. No information about expiration date was available. The reporter consented to follow up by fax. This case was linked with US2021159295, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021159295:Same reporter
Pt recvd vax in NOV92 & devel a rash; No further details were provided;
PATIENT ADVISED THAT SHE USUALLY PASSES OUT AFTER GETTING VACCINES. VACCINES ADMINISTERED AND ABOUT 3 MINS LATER PATIENT EXPERENCED A HYPOTONIC HYPORESPONSIVE EVENT. PATIENT WAS HELPED TO THE COT AND GIVEN JUICE AND AFTER ABOUT 15 MINS PATIENT STATED SHE WAS WELL ENOUGH TO LEAVE.
Vasovagal, regained consciousness right away. Gave water to drink with no issues.
Reddened area w/swelling @ inject site noticed AM 5APR91 about 2" long x 1" wide mom stated area felt warm to the touch;
I developed Shingles, which really sucks.  I was diagnosed by Dr.  I have a rash and a lot of pain.  I am on a course of anti-viral meds.
On the 30th I woke up at 5 AM nauseated - thought I would vomit - mouth filled with saliva, never vomited, just stayed nauseous and lasted for 3 days.
5-25-11 Tdap given - in morning (Wed). 5-27-11 (AM) - Rt arm soreness (Fri). 5-28-11 (Sat) - AM - Rt arm feels bruised, HA in sinus area pain 4/10 - took ADVIL and GOODY Powder, Rt arm painful 3/10. 5-30-11 (Mon) AM - HA ended. Rt arm still sore, bruised feeling, now reddened. 5-31-11 (Tues) AM - Eval by EH RN - Rt arm site red 14cm x 9cm at injection site, 1+ edema, deltoid site is very warm to touch, very tender to touch, cool compress applied, BENADRYL at hs.
This spontaneous report as received from a nurse refers to a patient of unknown age. On 29-AUG-2012 and 02-OCT-2012 ZOSTAVAX (lot #, expiration date unspecified) (0.65ml, subcutaneously) was administered both times inadvertently instead of VARIVAX (Merck). No adverse effects reported either time. Additional information has been requested.
approx 3"x3" sl raised erthemic lump to DT inject site;
Runny nose, sore throat, cough, watery eye with 10-15 minute blackouts numerous times a day.